Information Provided By: 
Fly News Breaks for September 18, 2017
BIO
Sep 18, 2017 | 05:37 EDT
Deutsche Bank analyst Dan Leonard says he now considers Bio-Rad Laboratories one of his top picks in Life Science Tools & Diagnostics. The company's market-leading position in digital polymerase chain reaction products is underappreciated by investors, Leonard tells investors in a research note titled "A Margin Story, But Don't Forget the Product Cycle!." The analyst adds that Bio-Rad "stands at the doorstep of the largest margin expansion opportunity in Tools." He has a Buy rating on the shares with a $255 price target.
News For BIO From the Last 2 Days
There are no results for your query BIO
